Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -16.84%2.48B | -14.29%5.59B | 0.35%2.99B | -18.19%6.52B | -26.33%2.98B | -15.49%7.97B | -17.90%6.03B | -21.04%4.04B | --2.12B | -3.34%9.43B |
| Operating income | -16.84%2.48B | -14.29%5.59B | 0.35%2.99B | -18.19%6.52B | -26.33%2.98B | -15.49%7.97B | -21.04%4.04B | -3.34%9.43B | ||
| Cost of sales | 10.22%-2.12B | 4.18%-5.92B | 1.10%-2.36B | 8.40%-6.18B | 28.00%-2.39B | 14.98%-6.74B | ---- | 23.70%-3.32B | ---- | 1.47%-7.93B |
| Operating expenses | 10.22%-2.12B | 4.18%-5.92B | 1.10%-2.36B | 8.40%-6.18B | 28.00%-2.39B | 14.98%-6.74B | 23.70%-3.32B | 1.47%-7.93B | ||
| Gross profit | -41.84%363.39M | -194.84%-327.96M | 6.22%624.84M | -71.88%345.78M | -18.66%588.24M | -18.19%1.23B | -6.02%723.22M | -12.11%1.5B | ||
| Selling expenses | 21.69%-25.25M | 19.62%-65.78M | -6.97%-32.25M | -24.12%-81.84M | -6.03%-30.15M | -15.83%-65.94M | ---- | 66.83%-28.43M | ---- | 58.21%-56.93M |
| Administrative expenses | 52.80%-309.41M | 7.88%-1.12B | -30.19%-655.54M | -3.77%-1.21B | 2.35%-503.54M | -5.46%-1.17B | ---- | 12.68%-515.65M | ---- | -5.39%-1.11B |
| Profit from asset sales | ---- | --133.05M | --146.42M | ---- | ---- | --401.77M | ---- | ---- | ---- | ---- |
| Impairment and provision | ---- | -9,136.64%-2.35B | ---- | ---25.45M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Impairment of property, machinery and equipment | ---- | ---1.98B | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairment is provision | ---- | -1,364.80%-372.73M | ---- | ---25.45M | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating interest expense | ---- | ---- | ---- | ---- | ---- | -124.16%-165.18M | ---- | 15.67%-55.15M | ---- | ---73.69M |
| Special items of operating profit | 63.57%88.94M | -333.13%-35.42M | -29.43%54.37M | -1.76%15.2M | 166.17%77.04M | -77.00%15.47M | ---- | -63.70%28.95M | ---- | -21.46%67.25M |
| Operating profit | -14.64%117.66M | -293.12%-3.76B | 4.75%137.84M | -483.87%-956.87M | -13.95%131.59M | -25.28%249.27M | 42.09%152.93M | -45.32%333.61M | ||
| Financing cost | 66.12%-25.41M | 50.90%-96.62M | 13.45%-75M | ---196.78M | ---86.65M | ---- | ---- | ---- | ---- | ---- |
| Share of profits of associates | ---- | -2,664.65%-13.13M | -453.04%-5.86M | --512K | --1.66M | ---- | ---- | ---- | ---- | ---- |
| Share of jointly controlled entity profit | ---- | ---- | ---- | ---- | ---- | 0.24%-30.27M | ---- | 3.42%-16.77M | ---- | -463.88%-30.34M |
| Earning before tax | 61.91%92.25M | -235.73%-3.87B | 22.26%56.98M | -626.54%-1.15B | -65.77%46.6M | -27.79%219M | 50.84%136.16M | -29.42%303.27M | ||
| Tax | 58.10%-8.67M | 37.07%-32.58M | -45.40%-20.68M | 23.08%-51.77M | 64.98%-14.22M | -31.02%-67.3M | ---- | -44.54%-40.61M | ---- | 26.75%-51.37M |
| After-tax profit from continuing operations | 130.29%83.59M | -224.00%-3.9B | 12.10%36.3M | -894.27%-1.2B | -66.11%32.38M | -39.78%151.7M | 53.69%95.55M | -29.94%251.9M | ||
| After-tax profit from non-continuing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---52.65M | ---- | ---8.63M |
| Earning after tax | 130.29%83.59M | -224.00%-3.9B | 12.10%36.3M | -894.27%-1.2B | -24.53%32.38M | -37.64%151.7M | -30.99%42.9M | -32.34%243.27M | ||
| Minority profit | -14.03%20.16M | 54.41%38.21M | 80.40%23.45M | 71.66%24.74M | 34.24%13M | -4.36%14.41M | ---- | 22.16%9.69M | ---- | 84.06%15.07M |
| Profit attributable to shareholders | 393.86%63.42M | -220.59%-3.94B | -33.73%12.84M | -995.68%-1.23B | -41.67%19.38M | -39.84%137.29M | -38.76%33.22M | -35.05%228.2M | ||
| Basic earnings per share | 400.00%0.0065 | -220.33%-0.4049 | -35.00%0.0013 | -996.45%-0.1264 | -41.18%0.002 | -51.21%0.0141 | -55.26%0.0034 | -41.62%0.0289 | ||
| Diluted earnings per share | 400.00%0.0065 | -220.33%-0.4049 | -35.00%0.0013 | -996.45%-0.1264 | -41.18%0.002 | -51.21%0.0141 | -55.26%0.0034 | -41.62%0.0289 | ||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | Debo Accounting Firm Limited | -- | Debo Accounting Firm Limited | -- | Ernst & Young Accounting Firm | -- | -- | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.